[

pfizer-biontech covid vaccine

]
Vials of the Pfizer/BioNTech vaccine in a cold room before being packaged for shipping.(AFP)

EU to get 50 million Pfizer doses early as Denmark scraps AstraZeneca

AFP |
UPDATED ON APR 14, 2021 08:39 PM IST
  • Johnson & Johnson said it would put off its European deliveries over reports of rare blood clots among people who had received the shot
France has approved use of the Pfizer/BioNTech and Moderna mRNA vaccines(MINT_PRINT)
France has approved use of the Pfizer/BioNTech and Moderna mRNA vaccines(MINT_PRINT)

France extends gap between mRNA vaccine shots to ramp-up rollout

Reuters |
PUBLISHED ON APR 11, 2021 09:21 AM IST
  • After a glacial start, France's vaccine rollout is hitting its stride, reaching a target of 10 million first doses a week ahead of a mid-April target.
The study will continue to track participants for two years for more information about long-term protection and safety.(AP)
The study will continue to track participants for two years for more information about long-term protection and safety.(AP)

Pfizer-BioNTech say Covid-19 vaccine 100% effective on youths aged 12 to 15

AP | | Posted by Kunal Gaurav
PUBLISHED ON MAR 31, 2021 04:27 PM IST
  • Most Covid-19 vaccines being rolled out worldwide are for adults, who are at higher risk from the coronavirus.
Vials labelled "Pfizer BioNtech coronavirus disease (COVID-19) vaccine" placed on the displayed EU flag are seen in this illustration picture taken on March 24, 2021. (REUTERS)
Vials labelled "Pfizer BioNtech coronavirus disease (COVID-19) vaccine" placed on the displayed EU flag are seen in this illustration picture taken on March 24, 2021. (REUTERS)

BioNTech aims to manufacture 2.5 billion Covid-19 vaccine doses this year

AP |
UPDATED ON MAR 30, 2021 05:47 PM IST
Pfizer and BioNTech had previously spoken of being able to make 2 billion doses in 2021.
German scientist, CEO and co-founder of BioNTech, Ugur Sahin.(Reuters)
German scientist, CEO and co-founder of BioNTech, Ugur Sahin.(Reuters)

Can get most Germans vaccinated by the end of summer: BioNTech founder

Reuters |
PUBLISHED ON MAR 21, 2021 07:40 AM IST
  • BioNTech founder Ugur Sahin said he was optimistic the problems would prove temporary, adding it was possible to ensure 70% of Germans were vaccinated by the end of September, at which point he said the virus would pose few problems.
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant(Twitter/consumerconnekt)

Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant

Reuters |
UPDATED ON MAR 09, 2021 08:23 AM IST
Pfizer has said it believes its current Covid-19 vaccine is highly likely to still protect against the South African variant but is planning to test a third booster dose of it as well as a version retooled specifically to combat the variant in order to better understand the immune response
The study, led by Cambridge researchers, has not yet been published or peer-reviewed, but the authors call it "real-world evidence for a high level of protection against asymptomatic SARS-CoV-2 infection" from a single dose of the vaccine. (Representative Image)(AFP)
The study, led by Cambridge researchers, has not yet been published or peer-reviewed, but the authors call it "real-world evidence for a high level of protection against asymptomatic SARS-CoV-2 infection" from a single dose of the vaccine. (Representative Image)(AFP)

Single dose of Pfizer Covid-19 vaccine may prevent asymptomatic infection: Study

ANI |
PUBLISHED ON FEB 26, 2021 09:44 PM IST
According to CNN, researchers used PCR tests to screen for coronavirus in vaccinated and non-vaccinated Cambridge University Hospitals health care workers who reported to work feeling well.
More than 4.6 million people have gotten at least one dose of the vaccine from Pfizer Inc. and BioNTech SE, according to Health Ministry data.(REUTERS)
More than 4.6 million people have gotten at least one dose of the vaccine from Pfizer Inc. and BioNTech SE, according to Health Ministry data.(REUTERS)

Israel gives half of population at least one Covid shot

Bloomberg |
PUBLISHED ON FEB 26, 2021 03:01 PM IST
Hospitals have seen a steady drop in critically ill cases over the past few weeks now that more than 90% of those in the highest risk groups have been vaccinated.
Fauci says the vaccines distributed in the US “clearly can take care of that particular strain.”(AP)
Fauci says the vaccines distributed in the US “clearly can take care of that particular strain.”(AP)

Anthony Fauci asks Americans to take whatever vaccine is available

AP |
PUBLISHED ON FEB 25, 2021 07:50 PM IST
  • Dr Anthony Fauci warns people not to hold off on getting the Johnson & Johnson vaccine while waiting for the slightly more effective Pfizer or Moderna shots.
Vials of Pfizer's coronavirus disease (Covid-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, US. (Reuters)
Vials of Pfizer's coronavirus disease (Covid-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, US. (Reuters)

Pfizer-BioNTech testing booster of their Covid-19 vaccine in new trial

Reuters |
PUBLISHED ON FEB 25, 2021 06:22 PM IST
"The rate of mutations in the current virus is higher than expected," Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.
The results of the study for the Clalit Research Institute were close to those in clinical trials last year which found two doses were found to be 95% effective.(REUTERS)
The results of the study for the Clalit Research Institute were close to those in clinical trials last year which found two doses were found to be 95% effective.(REUTERS)

In boost for Covid-19 battle, Pfizer vaccine found 94% effective in real world

Reuters |
PUBLISHED ON FEB 25, 2021 09:46 AM IST
The study of about 1.2 million people also showed a single shot was 57% effective in protecting against symptomatic infections after two weeks.
The companies said they have asked the US Food and Drug Administration to allow for the vaccine to be stored for up to two weeks at minus 25 to minus 15 degrees Celsius (minus 13 to five degrees Fahrenheit), temperatures commonly found in pharmaceutical freezers and refrigerators.(Reuters)
The companies said they have asked the US Food and Drug Administration to allow for the vaccine to be stored for up to two weeks at minus 25 to minus 15 degrees Celsius (minus 13 to five degrees Fahrenheit), temperatures commonly found in pharmaceutical freezers and refrigerators.(Reuters)

Pfizer, BioNTech say Covid-19 vaccine can withstand warmer temperatures

AFP |
PUBLISHED ON FEB 19, 2021 11:48 PM IST
Under the existing guidelines, the BioNTech/Pfizer jab needs to be stored at a frigid minus 80 to minus 60 C until five days before use, a delicate process that requires special ultra-cold containers for shipping and dry ice for storage.
Pregnant women are at higher risk of developing severe Covid-19, and many public health officials have recommended some women in high-risk professions take coronavirus vaccines even without proof they are safe for them.(Reuters)
Pregnant women are at higher risk of developing severe Covid-19, and many public health officials have recommended some women in high-risk professions take coronavirus vaccines even without proof they are safe for them.(Reuters)

Pfizer, BioNTech start testing Covid-19 vaccine in pregnant women

Reuters |
PUBLISHED ON FEB 19, 2021 06:41 PM IST
Pfizer Inc and BioNTech SE have started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their Covid-19 vaccine in healthy pregnant women, the companies said on Thursday.
The US Food and Drug Administration has not yet released a roadmap for how companies should design trials of booster shots(Bloomberg File Photo)
The US Food and Drug Administration has not yet released a roadmap for how companies should design trials of booster shots(Bloomberg File Photo)

Pfizer plans to test Covid-19 vaccine booster made for South African variant

Reuters |
PUBLISHED ON FEB 18, 2021 10:45 PM IST
The company is proposing to do a Phase I clinical trial of a booster shot of that prototype vaccine that it would test against a booster for the current vaccine.
The Pfizer-BioNTech study will be run in the US, Europe, South America, and Africa and focuses on the third trimester of pregnancy to minimise risk to unborn children (AP Photo/Jerome Delay, File)(AP)
The Pfizer-BioNTech study will be run in the US, Europe, South America, and Africa and focuses on the third trimester of pregnancy to minimise risk to unborn children (AP Photo/Jerome Delay, File)(AP)

Pfizer begins vaccine trial in pregnant women in a bid to fill global data void

Bloomberg |
PUBLISHED ON FEB 18, 2021 06:12 PM IST
Pfizer Inc. and BioNTech SE are starting trials for their vaccine in 4,000 women in the latter stages of pregnancy. They will run a mid-stage study for 350 volunteers between 27 and 34 weeks gestation to confirm safety before moving into advanced trials for women between 24 and 34 weeks pregnant.
Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided with the health authorities.(REUTERS)
Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided with the health authorities.(REUTERS)

Researchers urge delay in administering Pfizer vaccine's second dose

Reuters |
PUBLISHED ON FEB 18, 2021 04:16 PM IST
  • Two Canada-based researchers cautioned that there may be uncertainty about the duration of protection with a single dose, but said that the administration of the second dose a month after the first provided "little added benefit in the short term".
Researchers tested the engineered virus against blood taken from people who had been given the vaccine, and found a two- thirds reduction in the level of neutralizing antibodies compared with its effect on the most common version of the virus prevalent in US trials. (Representative Image)(Reuters)
Researchers tested the engineered virus against blood taken from people who had been given the vaccine, and found a two- thirds reduction in the level of neutralizing antibodies compared with its effect on the most common version of the virus prevalent in US trials. (Representative Image)(Reuters)

SA variant could reduce vaccine protection by two-thirds: Pfizer, BioNTech

Reuters |
UPDATED ON FEB 18, 2021 12:23 PM IST
The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.
Supplies of imported vaccines are a major concern because of supply shortages and restrictions in Europe, where many are manufactured.(REUTERS)
Supplies of imported vaccines are a major concern because of supply shortages and restrictions in Europe, where many are manufactured.(REUTERS)

Japan begins Covid-19 vaccination drive amid supply worry

PTI |
PUBLISHED ON FEB 17, 2021 07:28 AM IST
The government gave its belated first approval for shots developed and supplied by the Pfizer shots, already been used in many other countries since December.
The rate of symptomatic Covid-19 decreased by 94 per cent among people who received two doses of the vaccine, according to a press release from Clalit Research Institute.(AP)
The rate of symptomatic Covid-19 decreased by 94 per cent among people who received two doses of the vaccine, according to a press release from Clalit Research Institute.(AP)

Pfizer's Covid-19 vaccine sharply reduces symptomatic cases, says report

ANI |
PUBLISHED ON FEB 15, 2021 08:14 PM IST
The Clalit Research Institute analysed data on 1.2 million people, about half of whom had received the Pfizer-BioNTech vaccine. Researchers compared patients who received the vaccine with similar individuals who hadn't.
Lebanon's caretaker health minister Hamad Hasan administers a dose of the Pfizer/BioNTech vaccine in Beirut, Lebanon February 14, 2021.(REUTERS)
Lebanon's caretaker health minister Hamad Hasan administers a dose of the Pfizer/BioNTech vaccine in Beirut, Lebanon February 14, 2021.(REUTERS)

Lebanon starts Covid-19 vaccination drive, PM says will wait for his turn

Reuters |
PUBLISHED ON FEB 14, 2021 03:21 PM IST
Lebanon took delivery of 28,500 doses of the Pfizer-BioNTech vaccine on Saturday, the first batch of 2.1 million doses set to arrive in stages throughout the year.
Due to the ongoing evolution of the coronavirus, the study authors called for continuous monitoring of vaccine efficacy for emerging variants.(AP)
Due to the ongoing evolution of the coronavirus, the study authors called for continuous monitoring of vaccine efficacy for emerging variants.(AP)

Pfizer vaccine can neutralise coronavirus variants first reported in UK, SA

PTI |
PUBLISHED ON FEB 09, 2021 10:44 AM IST
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants.
Astra bowed to EU pressure and released its vaccine contract with the bloc.(Reuters file photo)
Astra bowed to EU pressure and released its vaccine contract with the bloc.(Reuters file photo)

EU poised to ban Covid-19 vaccine exports as shortage crisis mounts

Bloomberg |
PUBLISHED ON JAN 29, 2021 06:11 PM IST
The bloc’s Covid-19 vaccine push started at the end of December, later than the US and Britain.
Representational Image(AP)
Representational Image(AP)

Australia board asked about vaccine timeline for South Africa tour

Reuters |
PUBLISHED ON JAN 27, 2021 01:49 PM IST
Australia named a squad on Wednesday for the three-test tour which is expected to kick off later next month, though dates and venues are yet to be confirmed.
“I have every confidence we will get our deliveries as scheduled,” Nadhim Zahawi told LBC Radio on Tuesday. “Vaccine nationalism is the wrong way to go.”(via REUTERS)
“I have every confidence we will get our deliveries as scheduled,” Nadhim Zahawi told LBC Radio on Tuesday. “Vaccine nationalism is the wrong way to go.”(via REUTERS)

UK warns EU against ‘vaccine nationalism’ in row over supplies

Bloomberg |
PUBLISHED ON JAN 26, 2021 03:20 PM IST
  • The UK leads Europe in coronavirus vaccinations, with 6.6 million people -- about 10% of Britain’s population -- receiving a first dose as of Monday. There is growing anger in the EU about delivery delays from AstraZeneca Plc, which is expected to deliver fewer jabs than previously expected.
A general view picture shows people receiving the vaccination against the coronavirus disease (COVID-19) at a temporary healthcare maintenance organisation (HMO) centre, amid Israel's third national lockdown, at an underground parking lot in Givatayim Mall, near Tel Aviv, Israel January 19, 2021. REUTERS/Ammar Awad/Files(REUTERS)
A general view picture shows people receiving the vaccination against the coronavirus disease (COVID-19) at a temporary healthcare maintenance organisation (HMO) centre, amid Israel's third national lockdown, at an underground parking lot in Givatayim Mall, near Tel Aviv, Israel January 19, 2021. REUTERS/Ammar Awad/Files(REUTERS)

Israel includes teens in vaccination drive, eyeing exams

Reuters |
PUBLISHED ON JAN 24, 2021 05:51 PM IST
The vaccines were initially limited to the elderly and other high-risk categories, but are now available to anyone over 40 or - with parental permission - those between 16 and 18. The inclusion of late-teens is meant "to enable their return (to school) and the orderly holding of exams,'.
Some 5.38 million people have been given a first dose of vaccine in the UK, government data showed.(AP)
Some 5.38 million people have been given a first dose of vaccine in the UK, government data showed.(AP)

UK doctors call for shorter gap between Pfizer vaccine doses

Reuters |
PUBLISHED ON JAN 23, 2021 02:41 PM IST
The British Medical Association said it supports giving a second dose up to 42 days after the first dose, but that a longer gap is not in line with World Health Organization guidance. It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".
The affected doses which have not been administered are accounted for and will not be used(AFP)
The affected doses which have not been administered are accounted for and will not be used(AFP)

Sweden gives 1,000 people Covid-19 shots kept at wrong temperature

Reuters |
PUBLISHED ON JAN 22, 2021 08:19 PM IST
  • All of the people given doses from the faulty delivery are healthcare professionals. In total 2,100 vaccine doses - around 20% of what Sweden has so far received from Moderna - were kept at too low a temperature.
Pfizer has reduced the volume of the vaccine it will deliver to European Union countries this week.(AP)
Pfizer has reduced the volume of the vaccine it will deliver to European Union countries this week.(AP)

Poland says it could take legal action over Pfizer Covid-19 vaccine delay

Reuters |
PUBLISHED ON JAN 22, 2021 02:44 PM IST
Poland received 176,000 doses of the Pfizer/BioNTech vaccine, a drop of around 50% from what was expected."I think that such a decision (on legal action) could be made next month if these supplies are not completed in accordance with the manufacturer's declaration," said a government spokesman.
Pharmacist organizes the empty vials of the Pfizer-BioNTech Covid-19 vaccine.(AP)
Pharmacist organizes the empty vials of the Pfizer-BioNTech Covid-19 vaccine.(AP)

Pfizer to cut vaccine shipments as Belgian factory renovated

Bloomberg |
PUBLISHED ON JAN 16, 2021 05:22 AM IST
Pfizer and its German partner are under growing pressure to make more shots as countries around the world rush to immunize vulnerable people. The companies recently increased their output target for this year by more than 50% to 2 billion doses.
A vial of the Pfizer-BioNTech COVID-19, coronavirus vaccine is pictured ahead of starting inoculations at Mariebergsgarden care home in Nykoping, Sodermanland County, Sweden. (AFP)
A vial of the Pfizer-BioNTech COVID-19, coronavirus vaccine is pictured ahead of starting inoculations at Mariebergsgarden care home in Nykoping, Sodermanland County, Sweden. (AFP)

Six EU nations express 'severe concern' over vaccine delays

AFP |
PUBLISHED ON JAN 15, 2021 10:06 PM IST
  • Ministers from Denmark, Estonia, Finland, Latvia, Lithuania and Sweden said in their letter that the situation was "unacceptable" and "decreases the credibility of the vaccination process".
SHARE
  • 1
  • 2
  • ...
Story Saved